Navigation Links
Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter
Date:9/3/2014

al and toxicology studies, result of clinical trials, regulatory actions by the FDA and other regulatory agencies and the need for regulatory approvals, Palatin's ability to fund development of its technology and establish and successfully complete clinical trials, the length of time and cost required to complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not responsible for updating for events that occur after the date of this press release.

i Frank J et al. Diagnosis and Treatment of Female Sexual Dysfunction. AmFam Physician 2008; 77(5): 635-642.

ii Shifren JL et al. Sexual Problems and Distress in United States Women: Prevalence and Correlates. ObstetGynecol 2008;112 (5); 968-9.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Palatin Technologies Responds to Unusual Market Activity
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
3. Palatin Technologies Announces Option for License to Bremelanotide in Europe
4. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
5. Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
6. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
7. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
8. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
9. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
10. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
11. Global Markets and Technologies for Molecular Imaging Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... PARIS , Sept. 30, 2014 ... and NYSE: SNY) today announced that a Phase 2a ... IL-4 and IL-13 signaling, met all primary and secondary ... polyps (CSwNP) who did not respond to intranasal corticosteroids. ... dupilumab for use in the treatment of another allergic ...
(Date:9/29/2014)... PHILADELPHIA , Sept. 29, 2014  Repeated exposure ... life is associated with early childhood obesity, say researchers ... in a retrospective study based on data from ... The researchers found that children with ... infancy were particularly more likely to be at risk ...
(Date:9/29/2014)... DIEGO , 29 septembre 2014 ... (TSE : 4568) et Ambit Biosciences (NASDAQ : AMBI), ont ... fusion définitif en vertu duquel Daiichi Sankyo fera ... circulation d,Ambit Biosciences à 15 dollars par action ... d,achat qui sera suivie d,une fusion avec une ...
Breaking Medicine Technology:Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 2Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 3Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 4Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 6Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 7Antibiotic Use by Age 2 Associated with Obesity Risk 2Antibiotic Use by Age 2 Associated with Obesity Risk 3Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9
... AUSTIN, Texas, May 24, 2011 A paper published ... demonstrated that adding OVA1 to a physician,s preoperative ... ovarian cancers than a physician,s preoperative assessment alone. The ... the journal, which is the official publication of the ...
... Holdings, Inc. (OTCQB: ABHI), a leader in the development of ... has signed a new line of credit with East West ... to expire July 2011. The new line of credit expands ... the previous revolving line and extends the line by one ...
Cached Medicine Technology:OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 2OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 3OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 4AmbiCom Renews and Expands Line of Credit With East West Bank 2AmbiCom Renews and Expands Line of Credit With East West Bank 3
(Date:9/30/2014)... 30, 2014 Influenza is a significant ... can improve the efficacy of therapy, minimize overuse of ... disease in healthcare settings. Diagnostic tests available today vary ... The decision your laboratory makes in selecting the correct ... providers, is key to effective use of influenza diagnostics. ...
(Date:9/30/2014)... 3M has added four new thin VHB ... 3M 5906 , 3M 5907 , 3M ... which help create the strongest bond possible to a wide ... bonding to difficult surfaces such as paints, low surface energy ... and 5905 are designed specifically for electronic device engineers and ...
(Date:9/30/2014)... Seniors Guide will take part in running ... in Raleigh, to support Alzheimer’s North Carolina (AlzNC) in ... , Associate Publisher of Seniors Guide Magazine, Shannon Tippette, ... for the Raleigh-Durham-Chapel Hill areas of North Carolina for ... helping their team, “Eye of the Tiger”, reach their ...
(Date:9/30/2014)... 30, 2014 American Medical ID and ... agreement to raise awareness about Alzheimer’s disease and related ... people with these brain disorders. , American Medical ID ... AFA to the foundation to support its efforts to ... The ID bracelets and necklaces can be purchased via ...
(Date:9/30/2014)... Charlestown, RI (PRWEB) September 30, 2014 Dogs ... owner. Oftentimes, this involves spending time in the car travelling ... their canines have free run of the vehicle; however, this ... the owner as well. Royal Flush Havanese shares ... should always be routine practice. , There are many ways ...
Breaking Medicine News(10 mins):Health News:Alere Webinar Spotlights Optimal Flu Diagnostics to Keep Your Lab Ahead of the Curve 2Health News:Alere Webinar Spotlights Optimal Flu Diagnostics to Keep Your Lab Ahead of the Curve 3Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 2Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 3Health News:American Medical ID and Alzheimer’s Foundation of America Team up to Increase Awareness about Alzheimer’s Disease and Related Dementias 2Health News:American Medical ID and Alzheimer’s Foundation of America Team up to Increase Awareness about Alzheimer’s Disease and Related Dementias 3Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 2Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 3
... so does survival, study finds , MONDAY, Feb. 8 (HealthDay ... with increased risk of death, researchers say. , In a ... again at age 89 in a group of 555 participants ... at 85 and 89 years, and a greater decline in ...
... ... Strash, FACHE, Chief Executive Officer with Oro Valley Hospital, on critical issues facing healthcare ... ... timely communication among different segments of the medical community, Jackson & Coker ( www.jacksoncoker.com ...
... , CINCINNATI , Feb. 8 Three ... "about right," according to a study of more than 65,000 ... of obesity over the past several years, the number of ... 1999 and 2007," says Nicholas M. Edwards , MD, ...
... triggering bone formation , MONDAY, Feb. 8 (HealthDay News) -- ... osteoporosis in lab mice and rats, a new study has ... gut hinders bone formation. Most current drugs for osteoporosis only ... "New therapies that inhibit the production of serotonin in the ...
... BETHESDA, Md. , Feb. 8 /PRNewswire-Asia/ ... Western healthcare,products and services in the People,s Republic of China , today ... , , Financial Highlights:, -- Revenue in ... over year to $46.5 million;, -- Net ...
... ... McDonald, have formed One2One Partners. The firm creates customized programs that strengthen the relationship ... an engaged workforce and minimize the threat of third-party intervention, regardless of potential legislation ... ...
Cached Medicine News:Health News:Handgrip Strength Helps Predict Death Risk in Elderly 2Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 2Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 3Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 4Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 5Health News:Jackson & Coker Industry Report Spotlights Healthcare Executive Interview, 6Health News:New Study Shows Nearly One Third of Overweight Adolescents See Themselves as Underweight or 'About Right' 2Health News:New Study Shows Nearly One Third of Overweight Adolescents See Themselves as Underweight or 'About Right' 3Health News:Drug Cures Osteoporosis in Mice 2Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 2Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 3Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 4Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 5Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 6Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 7Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 8Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 9Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 10Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 11Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 12Health News:Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results 13Health News:Labor and Employee Relations Experts Form New Consulting Firm 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: